ReviewMetabolic brain disease2007
The treatment of hepatic encephalopathy.
Review in Metabolic brain disease, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.
- Probiotics for people with hepatic encephalopathy.The Cochrane database of systematic reviews · 2017Pooled it
- Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study.BMC gastroenterology · 2013Trial
- Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges.Nutrients · 2021Review
- Review
- Lactulose decreases neuronal activation and attenuates motor behavioral deficits in hyperammonemic rats.Metabolic brain disease · 2017Article
- Protein tolerance to standard and high protein meals in patients with liver cirrhosis.World journal of hepatology · 2017Article
- Delivery of glutamine synthetase gene by baculovirus vectors: a proof of concept for the treatment of acute hyperammonemia.Gene therapy · 2015Article
- Portosystemic shunt syndrome and endovascular management of hepatic encephalopathy.Seminars in interventional radiology · 2014Review
- Neurological complications post-liver transplantation: impact of nutritional status.Metabolic brain disease · 2013Review
- Management of hepatic encephalopathy by traditional chinese medicine.Evidence-based complementary and alternative medicine : eCAM · 2012Article
- Impaired gluconeogenesis in a porcine model of paracetamol induced acute liver failure.World journal of gastroenterology · 2011Article
- 'Gut health': a new objective in medicine?BMC medicine · 2011Article
- Pharmacotherapy for hepatic encephalopathy.Drugs · 2010Review
- Hepatic encephalopathy therapy: An overview.World journal of gastrointestinal pharmacology and therapeutics · 2010Article
- Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice.British journal of pharmacology · 2009Article
- Emerging Issues in Gastroenterology and Hepatology.Gastroenterology & hepatology · 2009Review
- The cat with neurological manifestations of systemic disease. Key conditions impacting on the CNS.Journal of feline medicine and surgery · 2009Review
- Brain Edema in Chronic Hepatic Encephalopathy.Journal of clinical and experimental hepatologyReview
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 8 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current recommendations for the treatment of hepatic encephalopathy are based, to a large extent, on open or uncontrolled trials, undertaken in very small numbers of patients. In consequence, there is ongoing discussion as to whether the classical approach to the treatment of this condition, which aims at reducing ammonia production and absorption using either non-absorbable disaccharides and/or antibiotics, should be revisited, modified or even abandoned. Pros and cons of present therapeutic strategies and possible future developments were discussed at the fourth International Hannover Conference on Hepatic Encephalopathy held in Dresden in June 2006. The content of this discussion is summarized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.